Mount Yale Investment Advisors, LLC Denali Therapeutics Inc. Transaction History
Mount Yale Investment Advisors, LLC
- $1.21 Billion
- Q2 2025
A detailed history of Mount Yale Investment Advisors, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Mount Yale Investment Advisors, LLC holds 201 shares of DNLI stock, worth $3,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
201Holding current value
$3,272% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DNLI
# of Institutions
251Shares Held
134MCall Options Held
148KPut Options Held
15.4K-
Black Rock Inc. New York, NY13.2MShares$214 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$192 Million0.0% of portfolio
-
Baillie Gifford & CO11.6MShares$189 Million0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.58MShares$107 Million0.01% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.26MShares$102 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.18B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...